Search results for "Societies"

showing 10 items of 230 documents

2019 ESC Guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society (ER…

2020

Guidelines summarize and evaluate available evidence with the aim of assisting health professionals in proposing the best management strategies for an individual patient with a given condition. Guidelines and their recommendations should facilitate decision making of health professionals in their daily practice. However, the final decisions concerning an individual patient must be made by the responsible health professional(s) in consultation with the patient and caregiver as appropriate.

ORAL ANTICOAGULANT-THERAPYdiagnosis[SDV]Life Sciences [q-bio]Medizin030204 cardiovascular system & hematologyEmbolectomyGuidelineRECURRENT VENOUS THROMBOEMBOLISM0302 clinical medicinePregnancyDaily practiceDiagnosisPulmonary medicineVenous thrombosisPulmonary MedicineThrombolytic TherapyDEEP-VEIN THROMBOSISDisease management (health)Societies MedicalComputingMilieux_MISCELLANEOUShealth care economics and organizationsRisk assessmentddc:616RIGHT-VENTRICULAR DYSFUNCTIONDisease ManagementShockMOLECULAR-WEIGHT HEPARINThrombolysishumanities3. Good healthPulmonary embolismEuropeAnticoagulation; Biomarkers; Diagnosis; Dyspnoea; Echocardiography; Embolectomy; Guidelines; Heart failure; Pregnancy; Pulmonary embolism; Right ventricle; Risk assessment; Shock; Thrombolysis; Treatment; Venous thromboembolism; Venous thrombosismedicine.veinEchocardiographyAcute DiseaseRight ventricleMedical emergencyCardiology and Cardiovascular MedicineRisk assessmentguidelines; pulmonary embolism; venous thrombosis; shock dyspnoea; heart failure: right ventricle: diagnosis; risk assessment: echocardiography; biomarkers; treatment; anticoagulation; thrombolysis; pregnancy; venous thromboembolism; embolectomyDiagnosiVenous thromboembolismthrombolysiseducationCardiologyMEDLINEThrombolysiHeart failure610 Medicine & healthGuidelinesInferior vena cava2705 Cardiology and Cardiovascular MedicineEXTRACORPOREAL MEMBRANE-OXYGENATION03 medical and health sciencesAnticoagulationMedicalDyspnoeamedicineHumansRIGHT HEART THROMBIVENTILATION-PERFUSION SCINTIGRAPHYshock dyspnoeaHealth professionalsbusiness.industryINFERIOR VENA-CAVA10031 Clinic for Angiologyheart failure: right ventricle: diagnosisPulmonary embolismAnticoagulantsbiomarkersrisk assessment: echocardiography030229 sport sciencesBiomarkermedicine.diseaseTreatmentINHALED NITRIC-OXIDESocietiesbusinessBiomarkers
researchProduct

Posttransplant Management of Recipients Undergoing Liver Transplantation for Hepatocellular Carcinoma. Working Group Report From the ILTS Transplant …

2020

Although liver transplantation (LT) is the best treatment for patients with localized hepatocellular carcinoma (HCC), recurrence occurs in 6%-18% of patients. Several factors, particularly morphological criteria combined with dynamic parameters, known before LT modify this risk and combined in prediction models may be used to stratify patients at need of variable surveillance strategies. Additional variables though likely explain differences in recurrence rates in patients with the same pre-LT HCC status. One of these variables is possibly immunosuppression (IS). Once recurrence takes place, management is highly heterogenous. Within the International Liver Transplantation Society Consensus …

OncologyAblation Techniquesmedicine.medical_specialtyCarcinoma HepatocellularConsensusmedicine.medical_treatmentConsensus Development Conferences as TopicMEDLINE030230 surgeryLiver transplantationMedical OncologyRisk Assessment03 medical and health sciences0302 clinical medicineRisk FactorsInternal medicinemedicineHumansIn patientGrading (tumors)Societies MedicalPostoperative CareTransplantationbusiness.industryLiver NeoplasmsConsensus conferenceImmunosuppressionChemoradiotherapy Adjuvantmedicine.diseasePrognosisUnited StatesLiver TransplantationQuality of evidenceEuropeTreatment OutcomeHepatocellular carcinomaPractice Guidelines as Topic030211 gastroenterology & hepatologyNeoplasm Recurrence Localbusiness
researchProduct

EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma

2018

Liver cancer is the fifth most common cancer and the second most frequent cause of cancer-related death globally. Hepatocellular carcinoma represents about 90% of primary liver cancers and constitutes a major global health problem. The following Clinical Practice Guidelines will give up-to-date advice for the clinical management of patients with hepatocellular carcinoma, as well as providing an in-depth review of all the relevant data leading to the conclusions herein. (C) 2018 European Association for the Study of the Liver. Published by Elsevier B.V. All rights reserved.

Oncologymedicine.medical_specialtyCarcinoma Hepatocellularmedicine.medical_treatmentMilan criteriaLiver transplantation03 medical and health sciences0302 clinical medicineResectable Hepatocellular CarcinomaHepatocellular carcinomaliver transplantation radiofrequenza ablation contrast enhanced Ultrasound antiangiogenetic drugs immunotherapyInternal medicinemedicineHumansEarly Hepatocellular CarcinomaSocieties MedicalHepatologybusiness.industryLiver NeoplasmsGastroenterologyDisease ManagementCancermedicine.diseaseBCLC Stage3. Good healthEurope030220 oncology & carcinogenesisHepatocellular carcinomaPractice Guidelines as Topic030211 gastroenterology & hepatologyLiver cancerbusinessJournal of Hepatology
researchProduct

Can ‘Fellow of the European Board of Ophthalmology Subspecialty Diploma in Glaucoma,’ a subspecialty examination on glaucoma induce the qualification…

2016

From 2015, the examination of Fellow of the European Board of Ophthalmology Subspecialty Diploma in Glaucoma (FEBOS-Glaucoma) was launched by the European Board of Ophthalmology (EBO) in cooperation with the European Glaucoma Society (EGS). This opinion aims at disclosing the background of the examination, prerequisite to the examination, and the value of the FEBOS-Glaucoma diploma.

Organes des sensgenetic structures020205 medical informaticsSpecialty boardophtalmologielcsh:MedicineGlaucoma02 engineering and technology0302 clinical medicineSpecialty Boards0202 electrical engineering electronic engineering information engineeringPractice Patterns Physicians'ComputingMilieux_MISCELLANEOUSSocieties Medicallcsh:LC8-6691Ophthalmologists3. Good healthClinical PracticeEurope[ SDV.MHEP.OS ] Life Sciences [q-bio]/Human health and pathology/Sensory OrgansGeneral Health ProfessionsClinical CompetenceCurriculumClinical competenceSpecializationEducational measurementmedicine.medical_specialtyOpinionSensory OrganseducationMédecine humaine et pathologieSubspecialtyEducation03 medical and health sciencesOphthalmologymedicineHumans[SDV.MHEP.OS]Life Sciences [q-bio]/Human health and pathology/Sensory OrgansFellowships and Scholarshipslcsh:Special aspects of educationbusiness.industrylcsh:RInternship and ResidencyGlaucomamedicine.diseaseeye diseasesOphthalmologyEducation Medical Graduate030221 ophthalmology & optometryOptometryHuman health and pathologysense organsEducational MeasurementbusinessJournal of Educational Evaluation for Health Professions
researchProduct

Recommendations for neonatologists and pediatricians working in first level birthing centers on the first communication of genetic disease and malfor…

2021

Abstract Background Genetic diseases are chronic conditions with relevant impact on the lives of patients and their families. In USA and Europe it is estimated a prevalence of 60 million affected subjects, 75% of whom are in developmental age. A significant number of newborns are admitted in the Neonatal Intensive Care Units (NICU) for reasons different from prematurity, although the prevalence of those with genetic diseases is unknown. It is, then, common for the neonatologist to start a diagnostic process on suspicion of a genetic disease or malformation syndrome, or to make and communicate these diagnoses. Many surveys showed that the degree of parental satisfaction with the methods of c…

ParentsRecommendations.Genetic diseaseDiseaseRecommendationsPediatricsCommunication of diagnosis0302 clinical medicineNeonatologistsPregnancyPrenatal DiagnosisNeonatalMedicine030212 general & internal medicineMedical diagnosisScientificSettore MED/38Intensive Care UnitsItalyGenetic DiseasesFemaleSocieties Scientificmedicine.medical_specialtyConsensusBest practiceConsensuGenetic CounselingTruth DisclosureBirthing CentersRJ1-570Defensive medicineCongenital Abnormalities03 medical and health sciences030225 pediatricsIntensive careIntensive Care Units NeonatalHumansNeonatologyPediatriciansCommunication of diagnosiModalitiesbusiness.industryResearchGenetic Diseases InbornBioethicsInbornFamily medicinebusinessMalformation syndromeSocieties
researchProduct

Familial hypercholesterolaemia: A global call to arms

2015

Familial Hypercholesterolaemia (FH) is the commonest autosomal co-dominantly inherited condition affecting man. It is caused by mutation in one of three genes, encoding the low-density lipoprotein (LDL) receptor, or the gene for apolipoprotein B (which is the major protein component of the LDL particle), or in the gene coding for PCSK9 (which is involved in the degradation of the LDL-receptor during its cellular recycling). These mutations result in impaired LDL metabolism, leading to life-long elevations in LDL-cholesterol (LDL-C) and development of premature atherosclerotic cardiovascular disease (ASCVD) [1], [2] and [3]. If left untreated, the relative risk of premature coronary artery d…

PathologyApolipoprotein BDisease030204 cardiovascular system & hematologymedicine.disease_causeGlobal HealthDISEASEDoenças Cardio e Cérebro-vasculares0302 clinical medicineHyperlipoproteinemia Type IISocieties MedicalRISK0303 health sciencesMutationbiology3. Good healthPREVALENCEEuropelipids (amino acids peptides and proteins)Cardiology and Cardiovascular MedicineFamilial hypercholesterolaemiaLife Sciences & Biomedicinemedicine.medical_specialtyHeterozygote1102 Cardiovascular Medicine And HaematologyHyperlipoproteinemia Type II03 medical and health sciencesInternal medicinemedicineHumans030304 developmental biologyScience & Technologybusiness.industryGUIDANCEPCSK9Heterozygote advantage1103 Clinical SciencesEndocrinologyPeripheral Vascular DiseaseCardiovascular System & HematologyReceptors LDLRECEPTORES DE LIPOPROTEÍNASRelative riskMutationbiology.proteinCardiovascular System & CardiologyFamilial HypercholesterolaemiabusinessCLINICIANLipoprotein
researchProduct

The social role of pediatrics in the past and present times.

2021

AbstractPediatrics and society are closely related. This link is as old as the history of Pediatrics, and dates to the second half of the eighteenth century. The vocation of the first European pediatric schools, indeed, was clinical and scientific, as well as social. The founding fathers of Pediatrics were scientists of great talent, and many of them benefactors and philanthropists. They spent their lives assisting the suffering childhood, and became promoters and organizers of social securities for the poorest and most vulnerable categories. The attention to the problems of abandonment was closely linked to study, prevention, and treatment of pathologies (especially infectious, deficiency …

Pediatric hospitalsHistory of pediatricsChildren’s carePediatricsRJ1-570EuropeSocioeconomic FactorsPediatricianHumansChildren Children’s care Pediatric hospitals History of pediatrics PediatricianPediatriciansChildLetter to the EditorChildrenSocieties MedicalItalian journal of pediatrics
researchProduct

Vitamin D in pediatric age: consensus of the Italian Pediatric Society and the Italian Society of Preventive and Social Pediatrics, jointly with the …

2018

Abstract Vitamin D plays a pivotal role in the regulation of calcium-phosphorus metabolism, particularly during pediatric age when nutritional rickets and impaired bone mass acquisition may occur. Besides its historical skeletal functions, in the last years it has been demonstrated that vitamin D directly or indirectly regulates up to 1250 genes, playing so-called extraskeletal actions. Indeed, recent data suggest a possible role of vitamin D in the pathogenesis of several pathological conditions, including infectious, allergic and autoimmune diseases. Thus, vitamin D deficiency may affect not only musculoskeletal health but also a potentially wide range of acute and chronic conditions. At …

Pediatricsmedicine.medical_specialtyConsensusAdolescentSupplementationConsensu030209 endocrinology & metabolismReviewAdolescentsVitaminvitamin D deficiencylaw.inventionNutritional Rickets03 medical and health sciences0302 clinical medicineRandomized controlled triallaw030225 pediatricsVitamin D and neurologymedicineMusculoskeletal healthHumansVitamin DChildPathologicalChildrenSocieties MedicalDietary Supplementvitamin D childrenVitamin d supplementationbusiness.industrylcsh:RJ1-570Infant NewbornInfantHypovitaminosis Dlcsh:PediatricsPediatric ageGeneral MedicineVitaminsmedicine.diseaseVitamin D DeficiencyItalyChild PreschoolPediatrics Perinatology and Child HealthDietary SupplementsDeficiencybusinessHumanItalian journal of pediatrics
researchProduct

Hypertension in the metabolic syndrome: Summary of the new position statement of the European Society of Hypertension

2009

Arterial hypertension is often part of a larger constellation of anthropometric and metabolic abnormalities that includes abdominal (or visceral) obesity, characteristic dyslipidemia (low high-density lipoprotein cholesterol and high triglycerides), glucose intolerance, insulin resistance and hyperuricemia. Using Adult Treatment Panel III criteria, prevalence is higher than in the general population and the metabolic syndrome (MS) can be found in as many as one third of patients. In hypertensives with MS, a high prevalence of hypertension-induced target organ damage and a negative prognostic value have been described. Dietary advice and life style changes should be strongly recommended and …

Pediatricsmedicine.medical_specialtyPopulationComorbidityInsulin resistanceInternal MedicinePrevalenceMedicineHumansHyperuricemiaeducationAntihypertensive AgentsSocieties MedicalMetabolic Syndromeeducation.field_of_studybusiness.industrymedicine.diseaseComorbidityObesityEuropeBlood pressureHypertensionPractice Guidelines as TopicMetabolic syndromebusinessRisk Reduction BehaviorDyslipidemia
researchProduct

Nomenclature and diagnosis of gluten-related disorders: A position statement by the Italian Association of Hospital Gastroenterologists and Endoscopi…

2017

Abstract Background “Gluten-related disorders” is a term that encompasses different diseases induced by the ingestion of gluten-containing food. Because of their incidence the scientific community has been intensively studying them. Aim To support gastroenterologists with a correct nomenclature and diagnostic approach to gluten-related disorders in adulthood. Methods The Italian Association of Hospital Gastroenterologists and Endoscopists (AIGO) commissioned a panel of experts to prepare a position statement clarifying the nomenclature and diagnosis of gluten-related disorders, focusing on those of gastroenterological interest. Each member was assigned a task and levels of evidence/recommen…

Pediatricsmedicine.medical_specialtySettore MED/09 - Medicina InternaGlutensNon-celiac gluten sensitivityWheat HypersensitivityDiseaseGastroenterologyDiagnosis DifferentialDiet Gluten-FreeHospital03 medical and health sciences0302 clinical medicineRisk FactorsFood allergyceliac disease; wheat allergy; non-celiac gluten sensitivity; gluten-related disorders; food allergyGluten-related disorderInternal medicineFood allergymedicineHumans030212 general & internal medicineRisk factorSocieties Medicalchemistry.chemical_classificationHepatologybusiness.industryRisk FactorIncidence (epidemiology)BIO/13 - BIOLOGIA APPLICATAGastroenterologynutritional and metabolic diseasesEvidence-based medicinemedicine.diseaseGlutenHospitalsWheat allergydigestive system diseasesCeliac DiseaseItalychemistry030211 gastroenterology & hepatologyDifferential diagnosisbusinessgluten-related disordersGlutenWheat allergyHuman
researchProduct